ProShare Advisors LLC

Position in OCGN — Ocugen, Inc.

CIK 1357955 BETHESDA, MD

Position in OCGN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$68,461

+$24,244 QoQ

Shares Held

44,746

-28.6% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#72

of 147 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $337,381,357 across 175 Biotechnology names. OCGN ranks #143 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	287,847	$142,982,240
2	REGN	Regeneron Pharmaceuticals, Inc.	119,240	$74,350,909
3	ALNY	Alnylam Pharmaceuticals, Inc.	128,514	$38,686,569
4	INCY	Incyte Corp	48,152	$5,458,510
5	MRNA	Moderna, Inc.	70,621	$4,945,588
6	CYTK	Cytokinetics Inc	27,121	$2,310,437
7	TECH	BIO-TECHNE Corp	30,597	$2,161,678
8	KRYS	Krystal Biotech, Inc.	4,760	$1,769,149

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$68,461	44,746	-28.6%	Shares	Sole	2026-08-11
2025-03-31	$44,217	62,631	-22.3%	Shares	Sole	2025-05-08
2024-12-31	$64,893	80,613	+66.7%	Shares	Sole	2025-02-14
2024-09-30	$47,964	48,351	+89.1%	Shares	Sole	2024-11-14
2023-03-31	$21,811	25,570	-8.5%	Shares	Sole	2023-05-26
2022-12-31	$36,338	27,953	+18.5%	Shares	Sole	2023-02-02
2022-09-30	$41,997	23,594	-1.9%	Shares	Sole	2022-11-07
2022-06-30	$54,582	24,045	-30.6%	Shares	Sole	2022-08-01
2022-03-31	$114,348	34,651	-14.1%	Shares	Sole	2022-05-10
2021-12-31	$183,565	40,344	+70.5%	Shares	Sole	2022-02-08
2021-09-30	$169,921	23,666	-50.6%	Shares	Sole	2021-11-12
2021-06-30	$384,685	47,906	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.